-
Short- and Longer-Term Healthcare Resource Utilization and Related Costs of Stroke in the Brazilian Private Market from 2019 to 2023
Mar 10, 2025, 14:00 PM -
Racial Disparity in Healthcare Expenditure Among Older Adults with Cardiovascular Diseases
Mar 10, 2025, 14:00 PM -
Ongoing Accelerated Approval Trends and What It Means for Patients
Mar 10, 2025, 14:00 PM -
Evaluating Imaging Artificial Intelligence (AI) Matching Real-World Digital Twins (rwDTs) Into an External Control Arm (ECA) for MYSTIC: A Phase 3 Clinical Trial in Metastatic Non-Small Cell Lung Cancer (mNSCLC)
Mar 10, 2025, 14:00 PM -
Characteristics of Patients Initiating Wegovy (Semaglutide) for Cardiovascular Risk Reduction in a Medicare Population
Mar 10, 2025, 14:00 PM -
Value Communications With US Payers: The Value of Storytelling
Mar 10, 2025, 14:00 PM -
A Systematic Literature Review on Symptom Burden and Impact of Disease on Quality of Life in Patients With Essential Thrombocythemia
Mar 10, 2025, 14:00 PM -
Antidiabetic Medication Uses Among Pregnant Women: Real-World Prescription Pattern in South Korea
Mar 10, 2025, 14:00 PM -
Health Technology Assessment in Saudi Arabia - Expectations for Oncology Product Eligibility Based on Predicate Canadian HTA
Mar 10, 2025, 14:00 PM -
Healthcare Resource Use in Commercially- and Medicaid-Insured Infants, Toddlers, and Children Diagnosed With Invasive Meningococcal Disease in the United States
Mar 10, 2025, 14:00 PM -
Time-Driven Activity-Based Costing in Healthcare: Should We Adjust for Inflation or Reapply the Method?
Mar 10, 2025, 14:00 PM -
Early Germline BRCA Testing in Breast Cancer: A Review of Value Frameworks and Cost-Effectiveness Analyses
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Adjuvant Pembrolizumab Versus Standard-of-Care (SOC) Immunotherapies (High-Dose interferon Alfa 2-b or Ipilimumab) in High-Risk Resected Melanoma in United States (US)
Mar 10, 2025, 14:00 PM -
Assessing Disease Severity: How HTA Bodiea Evaluate Unmet Needs and Influemce Decision-Making
Mar 10, 2025, 14:00 PM -
Prognostic Model for Overall Survival in Colorectal Cancer Patients in the US: A Real World Data Study
Mar 10, 2025, 14:00 PM -
Using Autonomous Generative AI Agents for Data Extraction from Clinical Study Reports: Accuracy Assessment Against Canada's Drug Agency Reports
Mar 10, 2025, 14:00 PM -
Impact of an Outpatient Rifaximin Access Program on 30-Day Readmission Rates in Hepatic Encephalopathy Patients Initiated on Rifaximin in the Inpatient Setting
Mar 10, 2025, 14:00 PM -
Performance Assessment and Validation of Real-World Response Data Generated Using a Deep Learning-Based Natural Language Processing Model Across Multiple Solid Tumors
Mar 10, 2025, 14:00 PM -
Qualitative Insights on Meaningful Change in Symptoms and Impacts for Patients With Alpha-1 Antitrypsin Deficiency
Mar 10, 2025, 14:00 PM -
Exploring Anemia and the Underdiagnosis of Myelofibrosis: Findings From a Real-World Retrospective Cohort
Mar 10, 2025, 14:00 PM
